ZIMMER BIOMET falls behind competitors

Trending News 🌥️

Zimmer Biomet Stock Intrinsic Value – Zimmer Biomet ($NYSE:ZBH), a large medical device company, lagged behind its competitors’ Wednesday. This caused its stock to fall. The main reason for this is that Zimmer Biomet has been slow to adapt to the changing medical landscape.

Its competitors have been quicker to embrace new technologies and develop new products. As a result, Zimmer Biomet has been losing market share. This trend is likely to continue in the future, unless the company can make some major changes.

Stock Price

On Wednesday, shares of Zimmer Biomet Holdings Inc opened at $108.7 and closed at $108.1, down by 0.8% from the prior closing price of $109.0. This decline comes as the company falls behind its competitors in the medical device industry. Zimmer Biomet has been struggling to keep up with its competitors in recent years, and this has taken a toll on the company’s stock price. While shares of rivals like Medtronic plc and Stryker Corporation have soared in recent years, Zimmer Biomet has lagged behind. One reason for this is that Zimmer Biomet has been slower to embrace new technologies like 3D printing, which is increasingly being used in the medical device industry. 3D printing offers a number of advantages, including the ability to create custom-made devices and the ability to produce smaller, more intricate devices.

Another reason for Zimmer Biomet’s struggles is the company’s heavy reliance on the U.S. market. About two-thirds of the company’s sales come from the U.S., which leaves it vulnerable to fluctuations in the country’s healthcare system. Investors have been increasingly concerned about these issues, and this has contributed to the decline in Zimmer Biomet’s stock price. If the company can’t turn things around soon, its shares are likely to continue to lag behind its competitors. Live Quote…

About the Company

VI Analysis – Zimmer Biomet Stock Intrinsic Value

Zimmer Biomet is a company that specializes in medical devices and equipment. The company’s stock is currently traded at $108.1, which represents a fair price that is undervalued by 18%. More…

VI Peers

The company operates in two segments, Reconstructive and Dental. It offers knee, hip, shoulder, elbow, hand and wrist, foot and ankle, and biologics products. The company also provides dental prosthetics, including dental implants and CAD/CAM systems; and digital equipment for dentists and laboratories. Zimmer Biomet has a market cap of $24.4 billion and is headquartered in Warsaw, Indiana.

– Alcon Inc ($LTS:0A0D)

Alcon Inc is a global medical company that specializes in eye care products and services. The company’s market cap as of 2022 is 30.09B, and its return on equity is 1.87%. Alcon’s products and services include contact lenses, intraocular lenses, ophthalmic surgical devices, and ophthalmic pharmaceuticals. The company has a presence in over 100 countries and serves customers in the retail, wholesale, and government sectors.

– Sonova Holding AG ($LTS:0QPY)

Sonova Holding AG is a Swiss manufacturer of hearing aids. The company was founded in 1947 and is headquartered in Zurich, Switzerland. As of 2020, Sonova Holding AG had a market cap of 15.37 billion Swiss francs and a return on equity of 18.9%. The company’s products are sold under the brand names Phonak, Unitron, and Advanced Bionics. Sonova Holding AG’s products are available in more than 100 countries.

– Tandem Diabetes Care Inc ($NASDAQ:TNDM)

Tandem Diabetes Care Inc is a medical device company that develops, manufactures and sells insulin pumps for people with diabetes. The company has a market cap of $2.56 billion and a return on equity of -8.79%. Tandem’s products include the t:slim X2 insulin pump, the t:flex insulin pump, and the t:slim G4 insulin pump. The company also offers the t:lock Connectivity System, a cloud-based software platform that allows users to manage their diabetes devices and data.

Summary

Zimmer Biomet is a publicly traded medical device company that designs, manufactures, and markets orthopedic products and services. Zimmer Biomet has a strong history of innovation and is committed to continued research and development in order to bring new and improved products to market. The company’s products are used in a wide variety of orthopedic procedures, including hip and knee replacements, spine surgery, and trauma surgery. Investing in Zimmer Biomet offers investors the potential for growth in a company with a strong history of innovation and a commitment to continued research and development.